Maltron BioScan touch i8 nano

Newborn Screening Tests

Information

Maltron BioScan touch i8 nano, the World’s Most Advanced Point-of-Care Fluid, Body Composition & Electrolytes Monitor. Engineered to redefine bedside diagnostics. Combining medical-grade accuracy with effortless usability, the BioScan touch i8 nano delivers rapid, non-invasive, multi-compartment analysis in seconds, empowering clinicians to make informed decisions at the point of care. At the heart of the BioScan touch i8 nano is its cutting-edge multi technology, finely tuned to quantify fluid status, Body composition and electrolytes indices with unmatched precision. What truly sets it apart is its integrated electrolyte assessment, providing actionable insights into sodium, potassium, chloride balance, data traditionally only available through invasive lab draws. This unique capability elevates the BioScan touch i8 nano beyond conventional body composition analysers and fluid monitors to a singular clinical platform. Designed for versatility across acute and chronic care environments, the BioScan touch i8 nano fits seamlessly into NICU, PICU, critical care, cardiology, nephrology, dialysis, oncology, endocrinology, sports medicine, and paediatric settings. Its intuitive touch interface delivers immediate results, trend tracking, and visual dashboards, supporting rapid assessment of fluid shifts, nutritional status, and electrolyte imbalances , enabling earlier intervention and improved patient outcomes. Portability and speed make it ideal for point-of-care workflows, from NICU bedsides and outpatient clinics to home health and field use. Workflow that eliminates needles, lines, and lab delays, the BioScan touch i8 nano leads a new era of non-invasive diagnostics. The BioScan touch i8 nano is not just a monitor, it’s the future of personalised fluid and metabolic care: fast, comprehensive, evidence-based, and available wherever patient care happens.
Maltron InternationalS7.F90MMaltron International Ltd is a UK-based medical technology company and a global pioneer in non-invasive fluid, body composition, and metabolic monitoring. With over four decades of scientific expertise, Maltron has established itself as a leader in advanced Multi technology diagnostic systems designed for real-world clinical decision-making at the point of care. Maltron is best known for its flagship platforms, the BioScan touch i8 and BioScan touch i8 nano, which represent the world’s most advanced multi-technology point-of-care monitors capable of assessing fluid distribution, body composition, and electrolytes in a single, rapid, non-invasive measurement. Unlike other conventional devices, Maltron systems are engineered for clinical environments, supporting adult, paediatric, neonatal, and preterm populations without exclusion. The company’s proprietary technology integrates multi technology this enables clinicians to move beyond simple weight or oedema assessment toward true precision fluid and metabolic management. Maltron works closely with hospitals, universities, and key opinion leaders worldwide, supporting clinical research, multi-centre studies, and guideline-driven innovation across nephrology, cardiology, intensive care, neonatology, oncology, nutrition, and metabolic medicine. Its solutions are used in acute care, chronic disease management, and research settings, helping clinicians detect risk earlier, guide interventions, and monitor response in real time. Operating under a robust ISO 13485 quality management system and aligned with international regulatory frameworks including UKCA, CE (EU MDR), and global market requirements, Maltron is committed to safety, scientific integrity, and continuous innovation. Maltron International Ltd is driven by a single mission: to deliver clinically meaningful, non-invasive diagnostics that improve patient outcomes by bringing advanced physiology insight directly to the bedside.

Log in

See all the content and easy-to-use features by logging in or registering!